Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene, SC Palmer… - Cochrane Database …, 2017 - cochranelibrary.com
Background Diabetes is the leading cause of end‐stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated …
Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, V Saglimbene… - Cochrane …, 2017 - researchnow.flinders.edu.au
Background: Diabetes is the leading cause of end-stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
[引用][C] Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene, SC Palmer… - Cochrane Database of …, 2017 - cir.nii.ac.jp
Glucose targets for preventing diabetic kidney disease and its progression | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene, SC Palmer… - Cochrane Database …, 2017 - cochranelibrary.com
Background Diabetes is the leading cause of end‐stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated …
[引用][C] Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene, SC Palmer… - COCHRANE …, 2017 - research.unipd.it
Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene… - The Cochrane …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Diabetes is the leading cause of end-stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
[PDF][PDF] Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene, SC Palmer… - status and date …, 2017 - unmfm.pbworks.com
Background Diabetes is the leading cause of end-stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
Glucose targets for preventing diabetic kidney disease and its progression.
M Ruospo, VM Saglimbene, SC Palmer… - The Cochrane …, 2017 - europepmc.org
Background Diabetes is the leading cause of end-stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene, SC Palmer… - COCHRANE …, 2017 - fair.unifg.it
Background: Diabetes is the leading cause of end-stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes-associated …
[HTML][HTML] Glucose targets for preventing diabetic kidney disease and its progression
M Ruospo, VM Saglimbene, SC Palmer… - The Cochrane …, 2017 - ncbi.nlm.nih.gov
Background Diabetes is the leading cause of end‐stage kidney disease (ESKD) around the
world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated …
world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated …